|
시장보고서
상품코드
2055083
의료용 모르핀 시장 : 투여 경로별, 용도별, 최종 사용자별, 제조 기원별, 농도별, 환자 연령층별, 유통 채널별, 지역별Medical Morphine Market, By Route of Administration, By Application, By End User, By Manufacturing Origin, By Strength, By Patient Age Group, By Distribution Channel, By Geography |
||||||
의료용 모르핀 시장은 2026년에 271억 3,000만 달러에 달하고 2033년까지 461억 9,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 7.9%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 271억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.90% | 시장 규모 예측(2033년) : | 461억 9,000만 달러 |
세계 의료용 모르핀 시장은 제약 업계의 중요한 부문으로, 주로 통증 관리 및 완화 치료를 위한 모르핀계 의약품의 제조, 유통 및 사용에 중점을 두고 있습니다. 아편 양귀비에서 추출되는 천연 유래 오피오이드 알칼로이드인 모르핀은 전 세계 임상 현장에서 극심한 통증 완화를 위한 표준 치료법으로 자리 잡고 있습니다. 이 필수적인 치료제는 특히 수술 후 관리, 암 치료, 임종 돌봄 상황에서 급성 및 만성 통증 관리에 없어서는 안 될 역할을 하고 있습니다.
의료용 모르핀 시장에는 즉시 방출 정제, 서방형 제제, 주사용 용액, 경구용 액제 등 환자의 특정 요구 사항과 임상적 요건을 충족하도록 설계된 다양한 제형이 포함되어 있습니다. 의료진은 환자의 삶의 질을 향상시키고 효과적인 통증 관리 프로토콜을 이행하기 위해 모르핀의 강력한 진통 효과에 크게 의존하고 있습니다. 이 시장의 중요성은 단순한 수익 창출에 그치지 않고, 전 세계 보건의료 성과와 환자의 복지에 직접적인 영향을 미치고 있습니다. 규제상의 과제나 오피오이드 의존에 대한 우려가 있음에도 불구하고, 심한 통증 관리에 있어 타의 추종을 불허하는 효능 덕분에 의료용 모르핀은 현대 의학에서 여전히 없어서는 안 될 존재입니다. 업계는 치료상의 이점을 유지하면서 잠재적 위험을 최소화하기 위해, 의약품 기술의 발전, 투여 메커니즘의 개선, 안전성 프로파일의 향상에 발맞추어 지속적으로 진화하고 있습니다.
시장 역학
세계 의료용 모르핀 시장은 국제적인 헬스케어 시스템 전반에 걸쳐 그 성장세를 뒷받침하는 몇 가지 강력한 요인들에 의해 주도되고 있습니다. 주요 요인은 전 세계적으로 만성 통증 질환, 암 환자 수 및 외과 수술 건수가 증가하고 있다는 점이며, 이로 인해 효과적인 통증 관리 솔루션에 대한 수요가 크게 증가하고 있습니다. 세계적인 고령화는 이러한 수요를 더욱 증폭시키고 있습니다. 노인들은 일반적으로 의료 과정을 거치는 동안 보다 집중적인 통증 관리 조치가 필요하기 때문입니다. 또한, 신흥 경제국에서의 의료 인프라 개선과 통증 관리 치료에 대한 접근성 향상도 시장 확대에 크게 기여하고 있습니다. 의료 종사자들 사이에서 적절한 통증 관리 지침과 치료 중인 환자의 안락함의 중요성에 대한 인식이 높아지면서, 임상 현장에서 모르핀 사용이 증가하고 있습니다.
그러나 시장은 오피오이드 처방에 대한 엄격한 규제 체계, 오피오이드 의존증 및 중독에 대한 우려 고조, 전 세계 규제 당국의 감시 강화 등 상당한 제약에 직면해 있습니다. 오피오이드 위기로 인해 의료 시스템은 더욱 엄격한 처방 지침을 도입해야 하는 상황에 놓여 있으며, 이는 시장 성장을 저해할 가능성이 있습니다. 게다가, 대체 통증 관리 요법과 비오피오이드계 진통제의 등장은 기존의 모르핀 기반 치료법에 있어 경쟁상의 과제가 되고 있습니다. 이러한 제약이 있음에도 불구하고, 시장 상황에는 큰 성장 기회가 존재합니다. 남용 방지 제제의 개발은 안전성 우려를 해소하는 동시에 시장 성장을 위한 유망한 길을 제시하고 있습니다. 개발도상 지역의 의료 접근성 확대는 특히 통증 관리 인프라가 아직 구축 단계에 있는 지역에서 미개척 시장 잠재력을 가져옵니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 의료용 모르핀 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 의료용 모르핀 시장에 관한 것으로, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계의 의료용 모르핀 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 의료용 모르핀 시장 : 투여 경로별(2021-2033년)
제5장 세계의 의료용 모르핀 시장 : 용도별(2021-2033년)
제6장 세계의 의료용 모르핀 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 의료용 모르핀 시장 : 제조 기원별(2021-2033년)
제8장 세계의 의료용 모르핀 시장 : 강도별(2021-2033년)
제9장 세계의 의료용 모르핀 시장 : 환자 연령층별(2021-2033년)
제10장 세계의 의료용 모르핀 시장 : 유통 채널별(2021-2033년)
제11장 세계의 의료용 모르핀 시장 : 지역별(2021-2033년)
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
KTH 26.06.19Medical Morphine Market is estimated to be valued at USD 27.13 Bn in 2026 and is expected to reach USD 46.19 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 27.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.90% | 2033 Value Projection: | USD 46.19 Bn |
The global medical morphine market represents a critical segment within the pharmaceutical industry, primarily focused on the production, distribution, and utilization of morphine-based medications for pain management and palliative care. Morphine, a naturally occurring opioid alkaloid derived from the opium poppy plant, serves as the gold standard for severe pain relief in clinical settings worldwide. This essential therapeutic agent plays an indispensable role in managing acute and chronic pain conditions, particularly in post-surgical care, cancer treatment, and end-of-life care scenarios.
The medical morphine market encompasses various formulations including immediate-release tablets, extended-release formulations, injectable solutions, and oral liquids, each designed to meet specific patient needs and clinical requirements. Healthcare providers rely heavily on morphine's potent analgesic properties to improve patient quality of life and ensure effective pain management protocols. The market's significance extends beyond mere revenue generation, as it directly impacts global healthcare outcomes and patient welfare. Despite regulatory challenges and concerns surrounding opioid dependency, medical morphine remains irreplaceable in modern medicine due to its unparalleled efficacy in severe pain management. The industry continues to evolve with advancing pharmaceutical technologies, improved delivery mechanisms, and enhanced safety profiles to maintain therapeutic benefits while minimizing potential risks.
Market Dynamics
The global medical morphine market is driven by several compelling factors that sustain its growth trajectory across international healthcare systems. The primary driver stems from the increasing prevalence of chronic pain conditions, cancer cases, and surgical procedures worldwide, creating substantial demand for effective pain management solutions. An aging global population further amplifies this demand, as elderly individuals typically require more intensive pain management interventions throughout their healthcare journey. Additionally, improved healthcare infrastructure in emerging economies and enhanced access to pain management therapies contribute significantly to market expansion. Growing awareness among healthcare professionals regarding proper pain management protocols and the importance of patient comfort during treatment has led to increased morphine utilization in clinical settings.
However, the market faces considerable restraints including stringent regulatory frameworks governing opioid prescriptions, growing concerns about opioid addiction and dependency, and increasing scrutiny from regulatory authorities worldwide. The opioid crisis has prompted healthcare systems to implement more restrictive prescribing guidelines, potentially limiting market growth. Furthermore, the emergence of alternative pain management therapies and non-opioid analgesics presents competitive challenges to traditional morphine-based treatments. Despite these restraints, significant opportunities exist within the market landscape. The development of abuse-deterrent formulations presents promising avenues for market growth while addressing safety concerns. Expanding healthcare access in developing regions offers untapped market potential, particularly in areas where pain management infrastructure is still developing.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global medical morphine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Viatris Inc., Hikma Pharmaceuticals plc, Aurobindo Pharma Ltd., Endo International plc, Mylan"¯N.V. (now Viatris), Merck"¯KGaA, Bristol"'Myers Squibb Company, Grunenthal GmbH, Sanofi S.A., and AbbVie Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global medical morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical morphine market
Market Segmentation
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Other routes (transdermal, suppository, intranasal, etc.)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Cancer"'related pain management
- Acute pain (post"'surgery, trauma, myocardial infarction)
- Chronic pain (arthritis, musculoskeletal disorders)
- Palliative and end"'of"'life care
- Other applications (e.g., diarrhea suppression, cough suppression)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Homecare/Home Healthcare Settings
- Other (rehabilitation centers, hospices)
- Manufacturing Origin Insights (Revenue, USD Bn, 2021 - 2033)
- Branded
- Generic
- Strength Insights (Revenue, USD Bn, 2021 - 2033)
- Low"'dose (e.g.≤10"¯mg)
- Medium"'dose (e.g.10"¯mg to ≤30"¯mg)
- High"'dose (30"¯mg)
- Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals plc
- Sun Pharmaceutical Industries Ltd.
- Johnson and Johnson
- Viatris Inc.
- Hikma Pharmaceuticals plc
- Aurobindo Pharma Ltd.
- Endo International plc
- Mylan"¯N.V. (now Viatris)
- Merck"¯KGaA
- Bristol"'Myers Squibb Company
- Grunenthal GmbH
- Sanofi S.A.
- AbbVie Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Medical Morphine Market, By Route of Administration
- Global Medical Morphine Market, By Application
- Global Medical Morphine Market, By End User
- Global Medical Morphine Market, By Manufacturing Origin
- Global Medical Morphine Market, By Strength
- Global Medical Morphine Market, By Patient Age Group
- Global Medical Morphine Market, By Distribution Channel
- Global Medical Morphine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Medical Morphine Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other routes (transdermal, suppository, intranasal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Medical Morphine Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cancer"'related pain management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute pain (post"'surgery, trauma, myocardial infarction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic pain (arthritis, musculoskeletal disorders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Palliative and end"'of"'life care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other applications (e.g., diarrhea suppression, cough suppression)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Medical Morphine Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare/Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other (rehabilitation centers, hospices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Medical Morphine Market, By Manufacturing Origin, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Medical Morphine Market, By Strength, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Low"'dose (e.g.≤10"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medium"'dose (e.g.>10"¯mg to ≤30"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High"'dose (>30"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Medical Morphine Market, By Patient Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Medical Morphine Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Medical Morphine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan"¯N.V. (now Viatris)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck"¯KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol"'Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
